Medtech in a Minute: Kicking off 2025 with M&AMedtech in a Minute: Kicking off 2025 with M&A

Stryker Strikes the M&A Trail Hard

Stryker started the new year with a bang as it agreed to acquire Inari Medical in a deal valued at $4.9 billion. The deal, which is expected to close by the end of the first quarter, signals the company's plans to stay active on the M&A trail, as management indicated in October.

Boston Scientific Charges Ahead with Bolt Medical Acquisition

Johnson & Johnson sent shockwaves through the cardiovascular intervention market last year with its $13.1 billion acquisition of Shockwave Medical, which now dominates the intravascular lithotripsy (IVL) space. Now, Boston Scientific is charging ahead with plans to acquire Bolt Medical, putting the company in direct competition with J&J for IVL market share. Boston Scientific has been a strategic investor in Bolt Medical since 2019 and has an existing equity stake of about 26%. 

J&J Hits the Pause Button on US PFA Cases

Johnson & Johnson hit the pause button on the U.S. external evaluation and all U.S. Varipulse cases as the New Brunswick, NJ-based company investigates the cause of four reported neurovascular events. As the U.S. external evaluation leveraged a unique platform configuration, J&J said, there is no impact on commercial activity and Varipulse pulsed field ablation (PFA) cases outside of the United States.

Related:Measuring Medtech's M&A Appetite in 2025